Total RNA of H1299 and A549 cells was extracted using
TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA), and RNA concentration, purity and integrity were measured. qPCR was performed using
SYBR® Premix-Ex-Taq™ II kit (Takara, Tokyo, Japan). qPCR was conducted on
ABI7500 FAST RT-PCR system (Thermo Fisher Scientific, Waltham, MA, USA). U6 was the internal reference for miR-221-3p, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was the internal reference for GAS5 and IRF2. Relative expressions were quantified using the 2
−ΔΔCt method. The primer sequences were as follows:
miR-221-3p forward :5′-GAAGAAATGATTCCAGGTAGC-3′.
miR-221-3p reverse :5′-TGAACATCCAGGTCTGGGGCA-3′.
GAS5 forward:5’-TGGTTCTGCTCCTGGTAACG-3’.
GAS5 reverse:5’-AGGATAACAGGTCTGCCTGC-3’.
U6 forward:5′-TGCGGGTGCTCGCTTCGGCAGC-3′.
U6 reverse:5′-CCAGTGCAGGGTCCGAGGT-3′.
GAPDH forward:5′-GCACCGTCAAGGCTGAGAAC-3′.
GAPDH reverse:5′-TGGTGAAGACGCCAGTGGA-3′.
IRF2 forward: 5′-TGAAGTGGATAGTACG GTGAACA-3′.
IRF2 reverse: 5′-CGGATTGGTGACAA TCTCTTG-3′.
Ma J., Miao H., Zhang H., Ren J., Qu S., Da J., Xu F, & Zhao H. (2021). LncRNA GAS5 modulates the progression of non-small cell lung cancer through repressing miR-221-3p and up-regulating IRF2. Diagnostic Pathology, 16, 46.